ACCESS Health International appoints N Krishna Reddy as CEO

Dr Sten Vermund has been inducted to ACCESS Health International’s Board of Directors

ACCESS Health International, a globally recognised health systems think tank and advisory group, announced two important leadership transitions. Dr N Krishna Reddy, who has been leading the operations as President across Asia, the Middle East, and North Africa, has been appointed Chief Executive Officer. Concurrently, the organisation welcomes to its Board of Directors, Dr Sten Vermund, Yale University Anna MR Lauder Professor of Public Health and a preeminent figure in pediatric medicine and infectious disease epidemiology.

This transition follows the leadership of Dr William Haseltine, the founder CEO and Chair, who will continue his invaluable contributions as Chair. Dr Reddy’s elevation to CEO marks a significant milestone in his illustrious career in healthcare and his tenure with ACCESS Health International. As a distinguished senior cardiologist, Dr Reddy has championed the cause of high-quality healthcare that is both affordable and accessible. His leadership has been instrumental in fostering collaborations, driving innovations, and expanding the organization’s footprint across Asia. Notably, he co-founded CARE Hospitals in 1997, a chain of tertiary care establishments spanning six states in India. His entrepreneurial acumen and clinical expertise have been pivotal in shaping ACCESS Health’s vision and strategies.

“It is an honour to be assigned the new responsibility, more so in the times of emerging health challenges arising from the convergence of global crises. The strong foundation laid over the past 15 years of ACCESS Health will support my efforts to convert the challenges into opportunities and move closer towards our vision,” Dr Reddy said on the occasion. 

Dr Sten Vermund’s appointment to the Board adds a layer of expertise and global perspective. Holding significant roles at the Yale School of Public Health, including his position as President of the Global Virus Network, Dr Vermund’s work has been transformative, especially in resource-limited settings. His groundbreaking research on HIV/AIDS, sexually transmitted infections, and more recently, COVID-19, underscores his commitment to combating infectious diseases. Furthermore, Dr Vermund’s innovative work on HIV-HPV interactions has catalysed policy changes and inspired global health initiatives, making him an invaluable addition to ACCESS Health International. 

Dr Vermund states, “ACCESS Health seeks to build local capacity and innovate in health system effectiveness in the regions of the world that do not have equitable healthcare access. I am most keen to assist in any way that I can as a member of its Board. In 2024 when we see so much strife and environmental threat in our world, the ACCESS mission is as critical as ever.” 


Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button